ETF Building Blocks Content Hub SBIO Rallies on M&A Announcements By Elle Caruso FitzgeraldAugust 10, 2022
Featured Biotech ETFs Rally as Global Blood Therapeutics Surges on Potential Pfizer Deal By Max ChenAugust 5, 2022
Featured Biotech ETFs Advance on Speculation of a Takeover Bid for Global Blood Therapeutics By Max ChenAugust 4, 2022
ETF Building Blocks Content Hub SBIO Increases on Biotech’s Sustained Rebound By Elle Caruso FitzgeraldJuly 20, 2022
ETF Building Blocks Content Hub SBIO Continues Rally on Breakthrough Drug Data By Elle Caruso FitzgeraldJune 29, 2022
ETF Building Blocks Content Hub Betting on Biotech Bear Market Expiration Date By Tom LydonMay 25, 2022
ETF Building Blocks Content Hub Make Biotech Cash Considerations With SBIO By Tom LydonMarch 28, 2022
ETF Building Blocks Content Hub Biotech Stocks, ETFs Starting to Look Healthier By Tom LydonMarch 21, 2022
ETF Building Blocks Content Hub SBIO Is a Good Place to Be for Biotech Innovation By Tom LydonFebruary 28, 2022
ETF Building Blocks Content Hub Get Ready for a Biotech ETF Comeback By Elle Caruso FitzgeraldFebruary 17, 2022
ETF Building Blocks Content Hub Consolidation Could Come Calling for Biotech in 2022 By Tom LydonJanuary 5, 2022
